Gritstone Bio Inc (NASDAQ:GRTS) finished Wednesday with a subtraction of -$0.01 to close at $1.19, a downside of -0.83 percent. An average of 2,180,080 shares of common stock have been traded in the last five days. There was a fall of -$0.1100 in the past week, and it reached a new high 6 times over the past 12 months. The last 20 days have seen an average of 872,270 shares traded, while the 50-day average volume stands at 614,458.
GRTS stock has decreased by -32.39% in the last month. The company shares reached their 1-month lowest point of $1.1393 on 09/26/23. With the stock rallying to its 52-week high on 01/09/23, shares of the company touched a low of $1.14 and a high of $4.05 in 52 weeks. It has reached a new high 3 times so far this year and lost -65.51% or -$2.2600 in price. In spite of this, the price is down -70.62% from the 52-week high.
Valuation Metrics
Gritstone Bio Inc (GRTS) stock’s beta is 0.65. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 40.87, the price-to-book (PB) ratio at 0.99.
Financial Health
The quick ratio of Gritstone Bio Inc for the recent quarter was 5.53, and the current ratio was 5.53, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.83 and a total debt to equity ratio of 0.87 for the recent quarter. Gritstone Bio Inc’s EBITDA margin is -1245.15%, while its operating margin for the same period stands at -5224.25%. Its gross profit as reported stood at $140.37 million compared to revenue of $19.95 million.
Earnings Surprise
For the recent quarter, Gritstone Bio Inc had $29.72 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$35.26 million in the quarter, while revenues of $33.98 million were grew 16.28%. Shareholders own equity worth $93.08 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Gritstone Bio Inc (GRTS) price momentum. RSI 9-day as of the close on 27 September was 15.63%, suggesting the stock is oversold, with historical volatility in this time frame at 35.21%.
As of today, GRTS’s price is $1.2160 -8.46% or -$0.1100 from its 5-day moving average. GRTS is currently trading -34.25% lower than its 20-day SMA and -50.83% lower than its 100-day SMA. However, the stock’s current price level is -46.15% below the SMA50 and -55.76% below the SMA200.
The stochastic %K and %D were 6.35% and 5.06%, respectively, and the average true range (ATR) was 0.1061. With the 14-day stochastic at 7.91% and the average true range at 0.1061, the RSI (14) stands at 21.94%. The stock has reached -0.1078 on the 9-day MACD Oscillator while the 14-day reading was at -0.2445.
Analyst Ratings
Evercore ISI launched coverage on Gritstone Bio Inc (NASDAQ: GRTS) in its analyst report released on March 31, 2023. The firm assigned the stock an Outperform rating.
